CINC Corp. Logo

CINC Corp.

Offers AI marketing analytics and SEO tools leveraging a vast Japanese keyword dataset.

4378 | T

Overview

Corporate Details

ISIN(s):
JP3372170005
LEI:
Country:
Japan
Address:
港区虎ノ門一丁目21−19
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

CINC Corp. is a data solutions company that utilizes big data, machine learning, and artificial intelligence to provide marketing analytics. Founded in 2014, the company develops and offers research and analysis tools designed to optimize digital marketing operations. Its core product, Keywordmap, leverages a proprietary and extensive Japanese keyword dataset to support clients with SEO strategy, competitor analysis, and market research. CINC aims to transform complex data into actionable insights, enabling businesses to enhance their online presence and strategic decision-making.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-13 09:01
Interim Report
確認書
Japanese 8.7 KB
2025-06-13 09:00
Interim Report
半期報告書-第12期(2024/11/01-2025/10/31)
Japanese 192.0 KB
2025-04-02 02:31
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.5 KB
2025-03-19 08:00
Major Shareholding Notification
臨時報告書
Japanese 20.7 KB
2025-01-30 04:18
Post-Annual General Meeting Information
臨時報告書
Japanese 24.3 KB
2025-01-29 08:01
Registration Form
確認書
Japanese 8.8 KB
2025-01-29 08:01
Governance Information
内部統制報告書-第11期(2023/11/01-2024/10/31)
Japanese 23.8 KB
2025-01-29 08:00
Registration Form
有価証券報告書-第11期(2023/11/01-2024/10/31)
Japanese 1020.3 KB
2024-09-04 08:12
Post-Annual General Meeting Information
訂正臨時報告書
Japanese 30.9 KB
2024-07-29 02:31
Post-Annual General Meeting Information
臨時報告書
Japanese 22.0 KB
2024-06-14 09:00
Report Publication Announcement
確認書
Japanese 8.8 KB
2024-06-14 09:00
Quarterly Report
四半期報告書-第11期第2四半期(2024/02/01-2024/04/30)
Japanese 207.4 KB
2024-03-14 08:01
Report Publication Announcement
確認書
Japanese 8.8 KB
2024-03-14 08:00
Quarterly Report
四半期報告書-第11期第1四半期(2023/11/01-2024/01/31)
Japanese 159.0 KB
2024-01-29 08:01
Post-Annual General Meeting Information
臨時報告書
Japanese 23.7 KB

Automate Your Workflow. Get a real-time feed of all CINC Corp. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CINC Corp.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CINC Corp. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Advancing high-grade copper and precious metal projects from discovery to production.
Canada
COR
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden
CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland
CTX
Cardiff Oncology, Inc. Logo
Clinical-stage biotech developing a PLK1 inhibitor to treat resistant cancers.
United States of America
CRDF
Cardio Diagnostics Holdings, Inc. Logo
AI-powered epigenetic and genetic tests for early detection of heart disease risk.
United States of America
CDIO
Cardiol Therapeutics Inc. Logo
Develops oral cannabidiol therapies for inflammatory and fibrotic heart diseases.
United States of America
CRDL
CareDx, Inc. Logo
Precision diagnostics and surveillance solutions for the organ transplant journey.
United States of America
CDNA
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan
6070
Caris Life Sciences, Inc. Logo
Pioneering precision cancer care via AI-powered molecular profiling and diagnostics.
United States of America
CAI
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan
4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.